The plasma PCSK9 level was elevated in GO patients and positively correlated with clinical inflammation and thyrotropin receptor antibody titer, indicating that PCSK9 is a potential biomarker for diagnosis and prognosis of GO. The gene discussed is PCSK9; the disease is geroderma osteodysplastica.